Published: October 11, 2025
0
0
2
šø SLE 2025 ā Where Are We Now? š¹ Chronic, relapsingāremitting autoimmune disease ā progressive organ damage š¹ Mortality & morbidity remain ā vs general population š¹ 5-year survival now >90% (vs 50% in 1950s) š¹ Advances in biologics & cell therapy transforming outlook āø»
š¹ Key Takeaways: Lupus Nephritis Updates (Dr. Manish Rathi, IRACON 2025) 1ļøā£ Proteinuria Evaluation ā¢Use first morning midstream sample š§Ŗ ā¢Prefer Urine ACR or Urine PCR (KDIGO 2024) 2ļøā£ Assess Kidney Early ā¢Start at disease onset: History, microscopy (look for dysmorphic
